Abstract

The in vivo effects of LMS were studied in 9 patients with A-T for a two month period. Among the various immunological parameters investigated following treatment with LMS, only the total lymphocyte count and the absolute number of E rosettes were found to be increased and serum IgM levels were reduced.

Keywords: ataxia-telangiectasia, hereditary immunodeficiency, levamisole therapy

How to cite

1.
Levendoğlu O, Berkel Aİ, Ersoy F, Sanal Ö. Levamisole therapy in ataxia-telangiectasia. Turk J Pediatr [Internet]. 1981 Dec. 25 [cited 2026 Nov. 20];23(4):255-9. Available from: https://turkjpediatr.org/article/view/4138